Unbiased Profile of MicroRNA Expression in Ascending Aortic Aneurysm Tissue Appoints Molecular Pathways Contributing to the Pathology

Annals of Thoracic Surgery

Volumn 102, Issue 4, 2016, Pages 1245-1252

  Licholai, Sabina ^a   Blaż, Michal ^a   Kapelak, Boguslaw ^b   Sanak, Marek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 126; MICRORNA 126 3P; MICRORNA 133A 3P; MICRORNA 140 3P; MICRORNA 143; MICRORNA 143 3P; MICRORNA 145 3P; MICRORNA 186 5P; MICRORNA 191 5P; MICRORNA 195 5P; MICRORNA 19B 3P; MICRORNA 20A 5P; MICRORNA 21 5P; MICRORNA 223 3P; MICRORNA 24; MICRORNA 24 3P; MICRORNA 26A 5P; MICRORNA 27A 3P; MICRORNA 28 3P; MICRORNA 29C 3P; MICRORNA 30D 5P; MICRORNA 328 3P; MICRORNA 34A 5P; MICRORNA 374 5P; MICRORNA 378A 5P; MICRORNA 486 5P; MICRORNA 661; MICRORNA 886 3P; NITRIC OXIDE; UNCLASSIFIED DRUG;

AGED; AORTA ANEURYSM; AORTIC TISSUE; ARTICLE; ASCENDING AORTA; BIOINFORMATICS; CELL AGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA TRANSCRIPTION; SMOOTH MUSCLE; SMOOTH MUSCLE CONTRACTILITY; AORTA; AORTIC ANEURYSM, THORACIC; COMPARATIVE STUDY; EPIDEMIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PATHOLOGY; PROCEDURES; REFERENCE VALUE; SPECIMEN HANDLING; VASCULAR SMOOTH MUSCLE;

AORTA; AORTIC ANEURYSM, THORACIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE VALUES; SAMPLING STUDIES; SPECIMEN HANDLING;

EID: 84969745103     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2016.03.061     Document Type: Article

References (33)

1. 1 El-Hamamsy, I., Yacoub, M.H., Cellular and molecular mechanisms of thoracic aortic aneurysms. Nat Rev Cardiol 6 (2009), 771–786.
2. 2 Ince, H., Nienaber, C.A., Etiology, pathogenesis and management of thoracic aortic aneurysm. Nat Clin Pract Cardiovasc Med 4 (2007), 418–427.
3. 3 Isselbacher, E.M., Thoracic and abdominal aortic aneurysms. Circulation 111 (2005), 816–828.
4. 4 De Backer, J., Campens, L., De Paepe, A., Genes in thoracic aortic aneurysms/dissections—do they matter?. Ann Cardiothorac Surg 2 (2013), 73–82.
5. 5 Jaenisch, R., Bird, A., Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33:Suppl (2003), 245–254.
6. 6 Lewis, B.P., Burge, C.B., Bartel, D.P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005), 15–20.
7. 7 van Rooij, E., The art of microRNA research. Circ Res 108 (2011), 219–234.
8. 8 Nazarov, P.V., Reinsbach, S.E., Muller, A., et al. Interplay of microRNAs, transcription factors and target genes: linking dynamic expression changes to function. Nucleic Acids Res 41 (2013), 2817–2831.
9. 9 Soifer, H.S., Rossi, J.J., Saetrom, P., MicroRNAs in disease and potential therapeutic applications. Mol Ther 15 (2007), 2070–2079.
10. 10 Hartmann, D., Thum, T., MicroRNAs and vascular (dys)function. Vascul Pharmacol 55 (2011), 92–105.
11. 11 Quintavalle, M., Condorelli, G., Elia, L., Arterial remodeling and atherosclerosis: miRNAs involvement. Vascul Pharmacol 55 (2011), 106–110.
12. 12 Kanzler, I., Rolle, K., El-Sayed Ahmad, A., et al. MiRNA modulation in ascending aortic aneurysms. Thorac Cardiovasc Surg, 61, 2013, OP189.
13. 13 Jones, J.A., Stroud, R.E., O'Quinn, E.C., et al. Selective microRNA suppression in human thoracic aneurysms: relationship of miR-29a to aortic size and proteolytic induction. Circ Cardiovasc Genet 4 (2011), 605–613.
14. 14 Boon, R.A., Seeger, T., Heydt, S., et al. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res 109 (2011), 1115–1119.
15. 15 Patuzzo, C., Pasquali, A., Malerba, G., et al. A preliminary microRNA analysis of non syndromic thoracic aortic aneurysms. Balkan J Med Genet 15:Suppl (2012), 51–55.
16. 16 Endogenous controls for real-time quantitation of miRNA using TaqMan microRNA assays. Available at: http://www3.appliedbiosystems.com/cms/groups/mcb_marketing/documents/generaldocuments/cms_044972.pdf. Accessed January 17, 2016.
17. 17 Pfaffl, M.W., Tichopad, A., Prgomet, C., Neuvians, T.P., Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: Bestkeeper—Excel-based tool using pair-wise correlations. Biotechnol Lett 26 (2004), 509–515.
18. 18 Vlachos, I.S., Kostoulas, N., Vergoulis, T., et al. DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res 40 (2012), W498–W504.
19. 19 Agarwal, V., Bell, G.W., Nam, J.W., Bartel, D.P., Predicting effective microRNA target sites in mammalian mRNAs. Elife, 4, 2015 Aug 12.
20. 20 Weber, M., Baker, M.B., Moore, J.P., Searles, C.D., Mir-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem Biophys Res Commun 393 (2010), 643–648.
21. 21 Pasta, S., Rinaudo, A., Luca, A., et al. Difference in hemodynamic and wall stress of ascending thoracic aortic aneurysms with bicuspid and tricuspid aortic valve. J Biomech 46 (2013), 1729–1738.
22. 22 Neth, P., Nazari-Jahantigh, M., Schober, A., Weber, C., MicroRNAs in flow-dependent vascular remodelling. Cardiovasc Res 99 (2013), 294–303.
23. 23 Lena, A.M., Mancini, M., Cervo, P.R.D., et al. MicroRNA-191 triggers keratinocytes senescence by SATB1 and CDK6 downregulation. Biochem Biophys Res Co 423 (2012), 509–514.
24. 24 Choke, E., Cockerill, G.W., Dawson, J., et al. Vascular endothelial growth factor enhances angiotensin II-induced aneurysm formation in apolipoprotein E–deficient mice. J Vasc Surg 52 (2010), 159–166.e151.
25. 25 Hong, F., Li, Y., Xu, Y., Decreased placental miR-126 expression and vascular endothelial growth factor levels in patients with pre-eclampsia. J Int Med Res 42 (2014), 1243–1251.
26. 26 Torella, D., Iaconetti, C., Catalucci, D., et al. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res 109 (2011), 880–893.
27. 27 Castoldi, G., Di Gioia, C.R.T., Bombardi, C., et al. MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J Cell Physiol 227 (2012), 850–856.
28. 28 Lowenstein, C.J., Dinerman, J.L., Snyder, S.H., Nitric oxide: a physiologic messenger. Ann Intern Med 120 (1994), 227–237.
29. 29 Gao, L., Siu, K.L., Chalupsky, K., et al. Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation: treatment with folic acid. Hypertension 59 (2012), 158–166.
30. 30 Mohamed, S.A., Radtke, A., Saraei, R., et al. Locally different endothelial nitric oxide synthase protein levels in ascending aortic aneurysms of bicuspid and tricuspid aortic valve. Cardiol Res Pract, 2012, 2012, 165957.
31. 31 Elia, L., Quintavalle, M., Zhang, J., et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 16 (2009), 1590–1598.
32. 32 Rangrez, A.Y., Massy, Z.A., Metzinger-Le Meuth, V., Metzinger, L., MiR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet 4 (2011), 197–205.
33. 33 Boon, R.A., Hergenreider, E., Dimmeler, S., Atheroprotective mechanisms of shear stress-regulated microRNAs. Thromb Haemost 108 (2012), 616–620.